Haverkate F - Search Results

1

The Dutch Vascular Factors in Dementia Study: rationale and design.

van Kooten F, Bots ML, Breteler MM, Haverkate F, van Swieten JC, Grobbee DE, Koudstaal PJ, Kluft C. van Kooten F, et al. Among authors: haverkate f. J Neurol. 1998 Jan;245(1):32-9. doi: 10.1007/s004150050171. J Neurol. 1998. PMID: 9457626 Clinical Trial.

2

Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, van Kooten F, Breteler MM, Slagboom PE, Hofman A, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: haverkate f. Haemostasis. 1998 May-Aug;28(3-4):209-15. doi: 10.1159/000022432. Haemostasis. 1998. PMID: 10420068

3

Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, Breteler MM, van Kooten F, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: haverkate f. Haemostasis. 1998 May-Aug;28(3-4):216-22. doi: 10.1159/000022433. Haemostasis. 1998. PMID: 10420069

4

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Circulation. 1997 Jun 17;95(12):2623-7. doi: 10.1161/01.cir.95.12.2623. Circulation. 1997. PMID: 9193430

5

Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?

van der Bom JG, de Maat MP, Bots ML, Haverkate F, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):621-5. doi: 10.1161/01.atv.18.4.621. Arterioscler Thromb Vasc Biol. 1998. PMID: 9555868

6

Fibrinolytic activity in peripheral atherosclerosis in the elderly.

van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Among authors: haverkate f. Thromb Haemost. 1999 Feb;81(2):275-80. Thromb Haemost. 1999. PMID: 10064006

7

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Among authors: haverkate f. Ann Intern Med. 1996 Aug 15;125(4):265-9. doi: 10.7326/0003-4819-125-4-199608150-00002. Ann Intern Med. 1996. PMID: 8678388

8

Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.

van der Bom JG, Bots ML, Haverkate F, Meijer P, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Thromb Haemost. 2001 Feb;85(2):234-9. Thromb Haemost. 2001. PMID: 11246539

9

The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1.

van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Blood. 2003 Mar 1;101(5):1841-4. doi: 10.1182/blood-2002-07-2181. Epub 2002 Oct 24. Blood. 2003. PMID: 12406875 Free article.

10

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function.

Verheggen PW, de Maat MP, Cats VM, Haverkate F, Zwinderman AH, Kluft C, Bruschke AV. Verheggen PW, et al. Among authors: haverkate f. Eur Heart J. 1999 Apr;20(8):567-74. doi: 10.1053/euhj.1998.1312. Eur Heart J. 1999. PMID: 10337541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters